Robert J Young Selected Research

Robert J Young Research Topics

Disease

41	Neoplasms (Cancer) 01/2024 - 09/2005
19	Brain Neoplasms (Brain Tumor) 12/2023 - 05/2013
10	Glioma (Gliomas) 01/2024 - 02/2016
9	Neoplasm Metastasis (Metastasis) 12/2023 - 01/2016
6	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 10/2015
5	Necrosis 09/2022 - 01/2016
5	Lung Neoplasms (Lung Cancer) 01/2020 - 01/2018
5	Melanoma (Melanoma, Malignant) 01/2020 - 01/2015
4	Radiation Injuries (Radiation Sickness) 07/2018 - 05/2013
3	Pituitary Neoplasms (Pituitary Adenoma) 08/2023 - 10/2018
3	Lymphoma (Lymphomas) 06/2021 - 09/2005
3	Disease Progression 01/2021 - 01/2018
3	Infections 12/2020 - 09/2005
3	Tuberculosis (Tuberculoses) 01/2018 - 01/2015
3	Type 2 Diabetes Mellitus (MODY) 02/2005 - 08/2002
2	Netherton Syndrome 01/2019 - 01/2019
2	Nausea 01/2018 - 12/2013
2	Critical Illness (Critically Ill) 09/2009 - 09/2007
1	Diabetic Foot 04/2024
1	Chagas Disease (American Trypanosomiasis) 10/2023
1	Visceral Leishmaniasis (Kala Azar) 10/2023
1	Prolactinoma (Prolactinomas) 08/2023
1	Craniopharyngioma (Craniopharyngiomas) 08/2023
1	Cysts 02/2023
1	Meningioma (Meningiomas) 01/2023
1	Breast Neoplasms (Breast Cancer) 04/2022
1	Circulating Neoplastic Cells 01/2021
1	Spinal Cord Ischemia 12/2020
1	Gliosis 01/2020
1	Inflammation (Inflammations) 01/2020
1	Adenocarcinoma of Lung 12/2019
1	Malaria 10/2019
1	Carcinogenesis 01/2019

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 01/2024 - 02/2016
6	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 11/2023 - 02/2016
5	Temozolomide (Temodar)FDA LinkGeneric 08/2023 - 10/2015
5	Bevacizumab (Avastin)FDA Link 01/2020 - 01/2016
4	Protons (Proton)IBA 05/2023 - 01/2021
3	Alkylating AgentsIBA 08/2023 - 10/2018
3	IpilimumabIBA 10/2021 - 01/2015
3	ErbB Receptors (EGF Receptor)IBA 01/2020 - 01/2018
2	osimertinibIBA 12/2023 - 01/2020
2	Cesium-131IBA 09/2022 - 09/2022
2	Immune Checkpoint InhibitorsIBA 04/2022 - 12/2019
2	Proteins (Proteins, Gene)FDA Link 04/2022 - 12/2020
2	NivolumabIBA 10/2021 - 10/2018
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 06/2021 - 01/2017
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2020 - 07/2018
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2019
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2020 - 01/2018
2	Kallikreins (Kallikrein)IBA 01/2019 - 01/2019
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019 - 01/2019
2	MethyltransferasesIBA 10/2018 - 01/2018
2	Fluorine-18IBA 01/2016 - 05/2013
2	Oxidoreductases (Dehydrogenase)IBA 12/2015 - 01/2015
2	Glucose (Dextrose)FDA LinkGeneric 02/2005 - 08/2002
1	Proteasome Endopeptidase Complex (Proteasome)IBA 10/2023
1	Proteasome InhibitorsIBA 10/2023
1	dabrafenibIBA 08/2023
1	Dopamine Agonists (Dopamine Agonist)IBA 08/2023
1	Everolimus FDA Link 08/2023
1	68Ga-pentixaforIBA 01/2023
1	Trastuzumab (Herceptin)FDA Link 04/2022
1	tremelimumabIBA 04/2022
1	lutetium Lu 177 dotatateIBA 10/2021
1	Radioisotopes (Radionuclides)IBA 10/2021
1	gallium Ga 68 dotatateIBA 10/2021
1	Somatostatin Receptors (Somatostatin Receptor)IBA 10/2021
1	Peptide Receptors (Peptide Receptor)IBA 10/2021
1	vorasidenibIBA 01/2021
1	ivosidenibIBA 10/2020
1	lorlatinibIBA 01/2020
1	cyclo(Arg-Pro) (CI 4)IBA 01/2020
1	fluorocholineIBA 01/2020
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2020
1	AminopeptidasesIBA 01/2020
1	Contrast MediaIBA 01/2020
1	EnzymesIBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	NestinIBA 01/2020
1	human ERBB2 proteinIBA 12/2019
1	ORALIT (ORS)IBA 12/2019
1	PurinesIBA 10/2019
1	purineIBA 10/2019
1	Nucleoside Transport Proteins (Nucleoside Transporter)IBA 10/2019
1	Mitogen-Activated Protein KinasesIBA 01/2019
1	selpercatinibIBA 01/2019

Therapy/Procedure

21	Therapeutics 12/2023 - 01/2016
12	Radiotherapy 08/2023 - 07/2012
4	Immunotherapy 10/2021 - 10/2018
4	Drug Therapy (Chemotherapy) 12/2020 - 12/2013
3	Craniospinal Irradiation 11/2022 - 01/2021
3	Glycemic Control 02/2005 - 08/2002
2	Brachytherapy 09/2022 - 09/2022
2	Re-Irradiation 09/2022 - 12/2021
2	Catheters 12/2020 - 09/2007
1	Surgical Amputation (Amputations) 04/2024
1	Craniotomy 02/2023
1	Proton Therapy 01/2021
1	Aftercare (After-Treatment) 12/2020